Clinical Trial Update: Golidocitinib Combined With Mitoxantrone Hydrochloride Liposome or Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on a Phase 1/Phase 2 study of golidocitinib combined with mitoxantrone hydrochloride liposome or chidamide for relapsed or refractory peri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• Chidamide (chidamide)
• Golidocitinib (golidocitinib)
• Mitoxantrone hydrochloride liposome (Mitoxantrone hydrochloride liposome)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Peripheral T Cell Lymphoma | Phase 1, Phase 2 | Status: RECRUITING